BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, March 29, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

In the clinic for May 6, 2021

May 6, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acelrx, AGTC, Altavant, Arcutis, Cytokinetics, Follicum, Hepion, Horizon, Humanigen, Isofol, Moderna, Moonlake, Nervgen, Novavax, Peptomyc, Revelation, Stealth, Surface Ophthalmics, Tetra, Zynerba.
Read More
Vaccine and data illustration

U.S. switches stance on IP waiver, sponsors promise revision

May 5, 2021
By Mari Serebrov
Once again, the World Trade Organization (WTO) postponed a decision on a temporary intellectual property (IP) waiver for COVID-19 vaccines and other related medical products.
Read More
Coins and charts

No spark for biopharmas in April

May 5, 2021
By Peter Winter
The rocky first quarter for public biopharmaceutical companies continued into April as the BioWorld Biopharmaceutical index remained flat for the period in contrast to the general market, with the Dow Jones Industrial Average growing by more than 2%. Weighing on the sector has been softer than expected earnings in the period among the top tier companies.
Read More

Other news to note for May 5, 2021

May 5, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Autogen, Axim Biotechnologies, Cell Projects, Centogene, CN Bio, Eagle Genomics, Empowered Diagnostics, Exagen, Femselect, Fluxergy, Gene Group Holdings, Genostics, Heartflow, Isohelix, Konica Minolta, Lina Medical USA, Medaxiom, Nvoq, Oncimmune, Perahealth, Rxbio, Sientra, Spectrum Solutions, Stagezero, United Health Products, US Medical Innovations, Vtnc.
Read More

Other news to note for May 5, 2021

May 5, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 4DMT, Alchemab, Astrazeneca, Alligator, Athenex, Celularity, Cytodyn, Dancann, Enesi, Errant Gene, Fraunhofer, GW, GX, Hoth, Ibio, Jazz, Kuur, Laboratorios Grin, Leadgen, Lupin, Mindmed, Mydecine, Nicox, Olix, Palantir, PCI, San Rocco, Takanawa, Takara, Tetra, Tiziana.
Read More

In the clinic for May 5, 2021

May 5, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adagio, Ascletis, Catalyst, Cerecor, Genascence, Genprex, Neoleukin, Oncopeptides, Tilt, Vivace.
Read More
Vaccination

Next up, Novavax, after April’s vaccine woes and therapeutic failures

May 4, 2021
By Karen Carey
Dangerous blood clots and thrombocytopenia, rare simultaneous side effects seen with two adenoviral vector vaccines from Astrazeneca plc and Johnson & Johnson, as well as a worldwide spike in COVID-19 cases and deaths, primarily in India, has set the stage for what could soon become the next big vaccine option, a protein subunit candidate from Gaithersburg, Md.-based Novavax Inc.
Read More

Other news to note for May 4, 2021

May 4, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 908 Devices, Avisa, Flurotest, Ivenix, Ivwatch, Moleculight, Premier, Sentinel Diagnostics, Smiths Medical, Vizient.
Read More

Regulatory actions for May 4, 2021

May 4, 2021
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astellas, Carmot, Clarity, Eli Lilly, Hutchmed, Immunomet, Newron, Pfizer, Quercis, R-Pharm Germany, Siga Technologies, Viiv Healthcare.
Read More

Other news to note for May 4, 2021

May 4, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abcellera, Abpro, Alligator, Aphios, APR, Aria, Astrazeneca, Aura, Bioarctic, Biocartis, Cartesian, CSL, Edgewise, Effector, Enesi, Esteve, Evotec, Exelixis, Gain, Gamamabs, Gemini, Gensight, Hcmed, Hoth, Hutchmed, Immunicum, J&J, Kowa, Lilly, Logicbio, Moderna, Moonlake, Merck KGaA, Nflection, Novobiome, Ocugen, Plus, Proqr, Recce, Relief, Samsung Bioepis, Sesen, Stoke, Twoxar, Xoma, Yarrow.
Read More
Previous 1 2 … 238 239 240 241 242 243 244 245 246 … 551 552 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 27, 2026.
  • Art concept for Parkinson's disease

    Emerging therapeutic strategies for Parkinson’s at ADPD 2026

    BioWorld
    Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
  • Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

    Small-molecule TREM2 agonist advances to treat Alzheimer’s

    BioWorld Science
    Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
  • Vials, syringes, and pills

    With improved technologies, biomarkers, failed drugs may come into their own

    BioWorld
    At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 24, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing